Edap Tms (EDAP) EBITDA Margin (2009 - 2026)
Edap Tms (EDAP) reported EBITDA Margin of 41.35% for Q1 2026, up 285.0% on a YoY basis from 10.74% in Q1 2025, and down 50.61% quarter-over-quarter from 27.46% in Q4 2025.
Edap Tms (EDAP) EBITDA Margin (2009 - 2026) Analysis & Trends
Edap Tms has reported EBITDA Margin for 18 years, with the latest figure at 41.35% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 285.0% year-over-year to 41.35%; the trailing twelve-month figure through Mar 2026 stood at 34.57% (up 10.0% YoY), and the FY2025 full-year result was 35.01%, down 339.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 41.35%, down from 27.46% in the prior quarter.
- The five-year high for EBITDA Margin was 0.86% in Q1 2022, with the low at 47.62% in Q3 2023.
- Historically, EBITDA Margin has averaged 28.77% across 5 years, with a median of 32.44% in 2024.
- Annual changes were most pronounced in 2023 — EBITDA Margin sank 4327 bps — and 2024, when it surged 1169 bps.
- Edap Tms' EBITDA Margin stood at 9.99% in 2022, then slumped by 78 bps to 17.75% in 2023, then retreated by 4 bps to 18.4% in 2024, then tumbled by 49 bps to 27.46% in 2025, then plunged by 51 bps to 41.35% in 2026.
- The last three EBITDA Margin figures came in at 41.35% (Q1 2026), 27.46% (Q4 2025), and 35.71% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 2.23% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 1.63% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 0.84% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 5.40% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 7.33% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -41.35% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -0.59% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -17.29% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.35% |
| Dec 31, 2025 | -27.46% |
| Sep 30, 2025 | -35.71% |
| Jun 30, 2025 | -35.43% |
| Mar 31, 2025 | -44.21% |
| Dec 31, 2024 | -18.40% |
| Sep 30, 2024 | -44.42% |
| Jun 30, 2024 | -39.01% |
| Mar 31, 2024 | -32.44% |
| Dec 31, 2023 | -17.75% |
| Sep 30, 2023 | -47.62% |
| Jun 30, 2023 | -29.64% |
| Mar 31, 2023 | -44.13% |
| Dec 31, 2022 | -9.99% |
| Sep 30, 2022 | -17.66% |
| Jun 30, 2022 | -3.07% |
| Mar 31, 2022 | -0.86% |
| Dec 31, 2021 | 3.30% |
| Sep 30, 2021 | -20.05% |
| Jun 30, 2021 | -4.13% |